Skip to main content
Erschienen in: HNO 10/2020

12.05.2020 | Kopf-Hals-Tumoren | Leitthema

Exosomen als Immunregulatoren in Kopf-Hals-Karzinomen

verfasst von: S. Ludwig, N. Rotter, M.-N. Theodoraki, J. Jablonska, A. Lammert, S. Lang

Erschienen in: HNO | Ausgabe 10/2020

Einloggen, um Zugang zu erhalten

Zusammenfassung

Exosomen, virusgroße Nanovesikel, werden als Botensysteme unseres Körpers zur Kommunikation mit anderen Körperzellen und Regulation von Immunfunktionen genutzt. Die von fast allen Körperzellen sezernierten Exosomen können unterwegs in der Blutzirkulation und in der Körperperipherie mit Immunzellen interagieren. Unterschiedliche Marker auf der Exosomenoberfläche sind für die Immunzelladhäsion und -interaktion nötig. Darüber hinaus sind mehrere Arten der Exosomen-Immunzell-Interaktion bereits bekannt, wie beispielsweise die direkte Oberflächenrezeptorinteraktion und Phagozytose. Als Transportmedium können Exosomen unterschiedliche Immunzelltypen in Kopf-Hals-Tumoren beeinflussen: Bisher sind T‑Zellen, natürliche Killerzellen, Makrophagen und dendritische Zellen in diesem Kontext beschrieben. Für diagnostische Zwecke könnte eine kombinierte Analyse unterschiedlicher Parameter, bestehend aus Proteinmenge, Nukleinsäure‑/Proteinexpression und dem immunsupprimierenden Effekt der Exosomen, ein wertvolles Hilfsmittel für die Beurteilung der Tumorentwicklung und -progression darstellen.
Literatur
1.
Zurück zum Zitat Baldini N, Torreggiani E, Roncuzzi L et al (2018) Exosome-like Nanovesicles isolated from citrus limon L. exert antioxidative effect. Curr Pharm Biotechnol 19:877–885CrossRef Baldini N, Torreggiani E, Roncuzzi L et al (2018) Exosome-like Nanovesicles isolated from citrus limon L. exert antioxidative effect. Curr Pharm Biotechnol 19:877–885CrossRef
2.
Zurück zum Zitat Bellmunt AM, Lopez-Puerto L, Lorente J et al (2019) Involvement of extracellular vesicles in the macrophage-tumor cell communication in head and neck squamous cell carcinoma. PLoS ONE 14:e224710CrossRef Bellmunt AM, Lopez-Puerto L, Lorente J et al (2019) Involvement of extracellular vesicles in the macrophage-tumor cell communication in head and neck squamous cell carcinoma. PLoS ONE 14:e224710CrossRef
3.
Zurück zum Zitat Blanchard N, Lankar D, Faure F et al (2002) TCR activation of human T cells induces the production of exosomes bearing the TCR/CD3/zeta complex. J Immunol 168:3235–3241CrossRef Blanchard N, Lankar D, Faure F et al (2002) TCR activation of human T cells induces the production of exosomes bearing the TCR/CD3/zeta complex. J Immunol 168:3235–3241CrossRef
4.
Zurück zum Zitat Burz C, Pop VV, Buiga R et al (2018) Circulating tumor cells in clinical research and monitoring patients with colorectal cancer. Oncotarget 9:24561–24571CrossRef Burz C, Pop VV, Buiga R et al (2018) Circulating tumor cells in clinical research and monitoring patients with colorectal cancer. Oncotarget 9:24561–24571CrossRef
5.
Zurück zum Zitat The Cancer Genome Atlas Network (2015) Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 517:576–582CrossRef The Cancer Genome Atlas Network (2015) Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 517:576–582CrossRef
6.
Zurück zum Zitat Chargaff E, West R (1946) The biological significance of the thromboplastic protein of blood. J Biol Chem 166:189–197PubMed Chargaff E, West R (1946) The biological significance of the thromboplastic protein of blood. J Biol Chem 166:189–197PubMed
7.
Zurück zum Zitat Chen T, Guo J, Yang M et al (2011) Chemokine-containing exosomes are released from heat-stressed tumor cells via lipid raft-dependent pathway and act as efficient tumor vaccine. J Immunol 186:2219–2228CrossRef Chen T, Guo J, Yang M et al (2011) Chemokine-containing exosomes are released from heat-stressed tumor cells via lipid raft-dependent pathway and act as efficient tumor vaccine. J Immunol 186:2219–2228CrossRef
8.
Zurück zum Zitat Cramer DW, O’rourke DJ, Vitonis AF et al (2010) CA125 immune complexes in ovarian cancer patients with low CA125 concentrations. Clin Chem 56:1889–1892CrossRef Cramer DW, O’rourke DJ, Vitonis AF et al (2010) CA125 immune complexes in ovarian cancer patients with low CA125 concentrations. Clin Chem 56:1889–1892CrossRef
9.
Zurück zum Zitat Crescitelli R, Lasser C, Szabo TG et al (2013) Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes. J Extracell Vesicles 2(1):20677CrossRef Crescitelli R, Lasser C, Szabo TG et al (2013) Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes. J Extracell Vesicles 2(1):20677CrossRef
10.
Zurück zum Zitat Fanini F, Fabbri M (2017) Cancer-derived exosomic microRNas shape the immune system within the tumor microenvironment: state of the art. Semin Cell Dev Biol 67:23–28CrossRef Fanini F, Fabbri M (2017) Cancer-derived exosomic microRNas shape the immune system within the tumor microenvironment: state of the art. Semin Cell Dev Biol 67:23–28CrossRef
11.
Zurück zum Zitat Frediani JN, Fabbri M (2016) Essential role of miRNAs in orchestrating the biology of the tumor microenvironment. Mol Cancer 15:42CrossRef Frediani JN, Fabbri M (2016) Essential role of miRNAs in orchestrating the biology of the tumor microenvironment. Mol Cancer 15:42CrossRef
12.
Zurück zum Zitat Ha D, Yang N, Nadithe V (2016) Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges. Acta Pharm Sin B 6:287–296CrossRef Ha D, Yang N, Nadithe V (2016) Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges. Acta Pharm Sin B 6:287–296CrossRef
13.
Zurück zum Zitat Hanahan D, Weinberg RA (2011) Hallmarks of cancer: The next generation. Cell 144:646–674CrossRef Hanahan D, Weinberg RA (2011) Hallmarks of cancer: The next generation. Cell 144:646–674CrossRef
14.
Zurück zum Zitat Hong CS, Funk S, Muller L et al (2016) Isolation of biologically active and morphologically intact exosomes from plasma of patients with cancer. J Extracell Vesicles 5:29289CrossRef Hong CS, Funk S, Muller L et al (2016) Isolation of biologically active and morphologically intact exosomes from plasma of patients with cancer. J Extracell Vesicles 5:29289CrossRef
15.
Zurück zum Zitat Kalluri R (2016) The biology and function of exosomes in cancer. J Clin Invest 126:1208–1215CrossRef Kalluri R (2016) The biology and function of exosomes in cancer. J Clin Invest 126:1208–1215CrossRef
16.
Zurück zum Zitat Lee TR, Choi M, Kopacz AM et al (2013) On the near-wall accumulation of injectable particles in the microcirculation: smaller is not better. Sci Rep 3:2079CrossRef Lee TR, Choi M, Kopacz AM et al (2013) On the near-wall accumulation of injectable particles in the microcirculation: smaller is not better. Sci Rep 3:2079CrossRef
17.
Zurück zum Zitat Ludwig S, Floros T, Theodoraki MN et al (2017) Suppression of lymphocyte functions by plasma exosomes correlates with disease activity in patients with head and neck cancer. Clin Cancer Res 23(16):4843–4854CrossRef Ludwig S, Floros T, Theodoraki MN et al (2017) Suppression of lymphocyte functions by plasma exosomes correlates with disease activity in patients with head and neck cancer. Clin Cancer Res 23(16):4843–4854CrossRef
18.
Zurück zum Zitat Ludwig S, Sharma P, Theodoraki MN et al (2018) Molecular and functional profiles of exosomes from HPV(+) and HPV(−) head and neck cancer cell lines. Front Oncol 8:445CrossRef Ludwig S, Sharma P, Theodoraki MN et al (2018) Molecular and functional profiles of exosomes from HPV(+) and HPV(−) head and neck cancer cell lines. Front Oncol 8:445CrossRef
19.
Zurück zum Zitat Maecker HT, Todd SC, Levy S (1997) The tetraspanin superfamily: molecular facilitators. FASEB j 11:428–442CrossRef Maecker HT, Todd SC, Levy S (1997) The tetraspanin superfamily: molecular facilitators. FASEB j 11:428–442CrossRef
20.
Zurück zum Zitat Mishra NC, Tatum EL (1973) Non-Mendelian inheritance of DNA-induced inositol independence in Neurospora. Proc Natl Acad Sci U S A 70:3875–3879CrossRef Mishra NC, Tatum EL (1973) Non-Mendelian inheritance of DNA-induced inositol independence in Neurospora. Proc Natl Acad Sci U S A 70:3875–3879CrossRef
21.
Zurück zum Zitat Muller L, Simms P, Hong CS et al (2017) Human tumor-derived exosomes (TEX) regulate Treg functions via cell surface signaling rather than uptake mechanisms. OncoImmunology 6:e1261243CrossRef Muller L, Simms P, Hong CS et al (2017) Human tumor-derived exosomes (TEX) regulate Treg functions via cell surface signaling rather than uptake mechanisms. OncoImmunology 6:e1261243CrossRef
22.
Zurück zum Zitat Pavlou MP, Diamandis EP (2010) The cancer cell secretome: a good source for discovering biomarkers? J Proteomics 73:1896–1906CrossRef Pavlou MP, Diamandis EP (2010) The cancer cell secretome: a good source for discovering biomarkers? J Proteomics 73:1896–1906CrossRef
23.
Zurück zum Zitat Schuh C, Cuenca J, Alcayaga-Miranda F et al (2019) Exosomes on the border of species and kingdom intercommunication. Transl Res 210:80–98CrossRef Schuh C, Cuenca J, Alcayaga-Miranda F et al (2019) Exosomes on the border of species and kingdom intercommunication. Transl Res 210:80–98CrossRef
24.
Zurück zum Zitat Sharma P, Ludwig S, Muller L et al (2018) Immunoaffinity-based isolation of melanoma cell-derived exosomes from plasma of patients with melanoma. J Extracell Vesicles 7:1435138CrossRef Sharma P, Ludwig S, Muller L et al (2018) Immunoaffinity-based isolation of melanoma cell-derived exosomes from plasma of patients with melanoma. J Extracell Vesicles 7:1435138CrossRef
25.
Zurück zum Zitat Silva M, Melo SA (2015) Non-coding RNAS in exosomes: new players in cancer biology. Curr Genomics 16:295–303CrossRef Silva M, Melo SA (2015) Non-coding RNAS in exosomes: new players in cancer biology. Curr Genomics 16:295–303CrossRef
26.
Zurück zum Zitat Theodoraki MN, Hoffmann TK, Whiteside TL (2018) Separation of plasma-derived exosomes into CD3((+)) and CD3((−)) fractions allows for association of immune cell and tumour cell markers with disease activity in HNSCC patients. Clin Exp Immunol 192:271–283CrossRef Theodoraki MN, Hoffmann TK, Whiteside TL (2018) Separation of plasma-derived exosomes into CD3((+)) and CD3((−)) fractions allows for association of immune cell and tumour cell markers with disease activity in HNSCC patients. Clin Exp Immunol 192:271–283CrossRef
27.
Zurück zum Zitat Theodoraki MN, Yerneni S, Gooding WE et al (2019) Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRT. Oncoimmunology 8:1593805CrossRef Theodoraki MN, Yerneni S, Gooding WE et al (2019) Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRT. Oncoimmunology 8:1593805CrossRef
28.
Zurück zum Zitat Theodoraki MN, Yerneni SS, Hoffmann TK et al (2018) Clinical significance of PD-L1(+) exosomes in plasma of head and neck cancer patients. Clin Cancer Res 24:896–905CrossRef Theodoraki MN, Yerneni SS, Hoffmann TK et al (2018) Clinical significance of PD-L1(+) exosomes in plasma of head and neck cancer patients. Clin Cancer Res 24:896–905CrossRef
29.
Zurück zum Zitat Whiteside TL (2016) Exosomes and tumor-mediated immune suppression. J Clin Invest 126:1216–1223CrossRef Whiteside TL (2016) Exosomes and tumor-mediated immune suppression. J Clin Invest 126:1216–1223CrossRef
30.
Zurück zum Zitat Zhang H, Freitas D, Kim HS et al (2018) Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation. Nat Cell Biol 20:332–343CrossRef Zhang H, Freitas D, Kim HS et al (2018) Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation. Nat Cell Biol 20:332–343CrossRef
Metadaten
Titel
Exosomen als Immunregulatoren in Kopf-Hals-Karzinomen
verfasst von
S. Ludwig
N. Rotter
M.-N. Theodoraki
J. Jablonska
A. Lammert
S. Lang
Publikationsdatum
12.05.2020
Verlag
Springer Medizin
Erschienen in
HNO / Ausgabe 10/2020
Print ISSN: 0017-6192
Elektronische ISSN: 1433-0458
DOI
https://doi.org/10.1007/s00106-020-00871-8

Weitere Artikel der Ausgabe 10/2020

HNO 10/2020 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.